Bristol- Myers to buy Celgene for $ 74 Bn. Bid to combine world’s two largest cancer drug businesses in biopharma deal. Deal to be paid with the combination of Stock & cash. With this deal combined firm to become fourth largest pharmaceutical firm in US. Shares of Bristol-Myers fall by 13% & shares of Celgene jumped 20% in recent trading.
